FDA raised conflict of interest concerns ahead of new peptide panel - The Washington Post

FDA raised conflict of interest concerns ahead of new peptide panel - The Washington Post
Health

Listen to this article

0%

As the Trump administration was assembling a key panel to review a slate of controversial peptides, FDA officials expressed concerns about appointing those who worked for peptide-related businesses a… [+187 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected